cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragije - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
zalna 10 mg/0,25 mg v 1 g gel
meda pharma gmbh & co. kg - klindamicin; tretinoin - gel - klindamicin 10 mg / 1 g tretinoin0,25 mg / 1 g; tretinoin 0,25 mg / 1 g - klindamicin, kombinacije
zalna 10 mg/0,25 mg v 1 g gel
meda pharma gmbh & co. kg - klindamicin, tretinoin - gel - klindamicin 10 mg / 1 g; tretinoin 0,25 mg / 1 g - klindamicin, kombinacije
efmody
diurnal europe b.v. - hidrokortizon - adrenal hyperplasia, congenital - kortikosteroidi za sistemsko uporabo - treatment of congenital adrenal hyperplasia (cah) in adolescents aged 12 years and over and adults.
spongostan spugna di gelatina emostatica riassorbibile
spongostan spugna di gelatina emostatica riassorbibile
spongostan polvere di gelatina emostatica riassorbibile
lekadol combo 500 mg/ 12,2 mg prašek za peroralno raztopino
lek d.d. - fenilefrin; paracetamol - prašek za peroralno raztopino - fenilefrin 10 mg / 1 vrečica paracetamol500 mg / 1 vrečica; paracetamol 500 mg / 1 vrečica - paracetamol, kombinacije brez psiholeptikov